Holen Sie sich die Stockscreener-App
11.28
1.40%
0.1871
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$11.09
Offen:
$11.19
24-Stunden-Volumen:
391.45K
Relative Volume:
0.12
Marktkapitalisierung:
$2.25B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-5.4479
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+11.56%
1M Leistung:
-14.22%
6M Leistung:
-27.31%
1J Leistung:
-41.40%
1-Tages-Spanne:
$11.03
$11.29
1-Wochen-Bereich:
$9.85
$11.27
52-Wochen-Spanne:
$9.85
$20.59
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
11.29 | 2.21B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
577.42 | 205.21B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.72 | 56.03B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
79.90 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
256.33 | 37.34B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
278.29 | 20.20B | 2.96B | 487.70M | 344.00M | 6.6758 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
How DENTSPLY SIRONA Inc. stock benefits from strong dollarTrade Entry Report & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Insider Buying: Leslie Varon Acquires Shares of Dentsply Sirona Inc (XRAY) - GuruFocus
Dentsply Sirona ticks up after interim CFO appointment (XRAY:NASDAQ) - Seeking Alpha
Dentsply Sirona names Michael Pomeroy interim CFO as search for permanent successor continues - Investing.com India
Dentsply Sirona Inc appoints Michael Pomeroy as interim CFOSEC filing - MarketScreener
Dentsply Sirona names Michael Pomeroy interim CFO as search for permanent successor continues By Investing.com - Investing.com South Africa
DENTSPLY SIRONA Appoints Interim CFO Michael Pomeroy - TipRanks
DENTSPLY SIRONA Inc. Announces Chief Financial Officer Changes - MarketScreener
Is Dentsply Sirona (XRAY) Undervalued After Recent Share Price Decline? - Yahoo Finance
AXQ Capital LP Has $595,000 Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Why Analysts See the Story Changing for DENTSPLY SIRONA Amid Lowered Targets and New Risks - Yahoo Finance
Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know - The Globe and Mail
How buybacks impact DENTSPLY SIRONA Inc. stock valueVolume Spike & Verified Chart Pattern Signals - newser.com
Dentsply Sirona Faces Weak Start with 9% Gap Down Amid Market Concerns - Markets Mojo
Dentsply Sirona: Advancing endodontics through evidence, quality and innovation - Dental Tribune US
What insider purchases suggest about DENTSPLY SIRONA Inc. (DY2) stockOil Prices & AI Optimized Trading Strategy Guides - newser.com
DENTSPLY SIRONA (NASDAQ:XRAY) Sets New 52-Week LowTime to Sell? - MarketBeat
United States Intraoral Radiography Market 2025: Industry - openPR.com
Is DENTSPLY SIRONA Inc. stock recession proofJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
Why DENTSPLY SIRONA Inc. stock attracts high net worth investorsEarnings Recap Report & Technical Confirmation Trade Alerts - newser.com
Analyzing net buyer seller activity in DENTSPLY SIRONA Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
What makes DENTSPLY SIRONA Inc. stock attractive to growth fundsM&A Rumor & Long-Term Safe Investment Ideas - newser.com
How to read the order book for DENTSPLY SIRONA Inc.2025 AllTime Highs & Advanced Swing Trade Entry Alerts - newser.com
Is DENTSPLY SIRONA Inc. stock a safe buy before earningsJuly 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com
Understanding DENTSPLY SIRONA Inc.’s price movementGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Is now a turning point for DENTSPLY SIRONA Inc.Market Risk Report & Daily Stock Momentum Reports - newser.com
Will DENTSPLY SIRONA Inc. (DY2) stock issue positive guidanceJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
DENTSPLY SIRONA Inc.’s volatility index tracking explainedTrade Exit Summary & Technical Confirmation Trade Alerts - newser.com
DENTSPLY SIRONA Inc. stock prediction for this week2025 Trade Ideas & Free Accurate Trade Setup Notifications - newser.com
Is DENTSPLY SIRONA Inc. building a consolidation baseTrade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 61,608 DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (WBAG:XRAY) Price Target Decreased by 19.27% to 11.21 - Nasdaq
Will DENTSPLY SIRONA Inc. (DY2) stock deliver stable dividendsJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
DENTSPLY SIRONA (BIT:1XRAY) Price Target Decreased by 17.49% to 11.48 - Nasdaq
News impact scoring models applied to DENTSPLY SIRONA Inc.Quarterly Market Review & Precise Trade Entry Recommendations - newser.com
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LUCIER GREGORY T | Director |
Mar 03 '25 |
Buy |
16.51 |
15,142 |
249,994 |
81,971 |
0.99%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):